• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用2MHz飞秒激光平台进行角膜屈光透镜切除术的初始视觉和屈光结果

Initial Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction Using 2MHz Femtosecond Laser Platform.

作者信息

Desai Anuja, Kinkhabwala Ravish, Mehta Parin, Prajapati Bhavik

机构信息

Department of Ophthalmology, Kusum Dhirajlal Hospital, Ahmedabad, Gujarat, India.

出版信息

Clin Ophthalmol. 2025 Sep 18;19:3431-3437. doi: 10.2147/OPTH.S548323. eCollection 2025.

DOI:10.2147/OPTH.S548323
PMID:40989066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12453037/
Abstract

PURPOSE

To report the initial refractive and visual outcomes of keratorefractive lenticule extraction (KLEx) procedures using the 2MHz femtosecond laser platform in myopia and myopic astigmatism.

METHODS

All eyes meeting the following inclusion and exclusion criteria from April to June 2024 were selected for the study. The study included patients >18 years of age with vision 20/25 or better, myopia with SEQ of -0.5D to -12.5D, residual stromal thickness >300 microns and stable refraction for one year. Excluded were those with hypermetropia, mixed astigmatism, corneas <480 microns, corneal diseases, active illnesses, pregnancy, abnormal corneal shape, and patients not able to commit to a 3-month follow-up.

RESULTS

A total of 198 eyes (102 patients) comprising 45 (44.1%) females and 57 (55.9%) males, with a mean age of 23.9 ± 4.8 years, were considered for statistical analysis. 90.4% of the eyes achieved 20/20 UDVA or better after surgery. Correlation between attempted SEQ and achieved SEQ was 0.9636 implying high predictability. Our study demonstrated high accuracy with 100% eyes achieving SEQ ± 1.00D of intended target and 91.9% of eyes within 0.5D of intended target SEQ. The present study confirms the refractive stability with minimal changes (-0.04D relative to the intended target) over 3 months of follow up.

CONCLUSION

The present study shows that the KLEx procedure is highly efficacious and safe, with visual and refractive outcomes showing good predictability and stability.

摘要

目的

报告使用2MHz飞秒激光平台进行角膜屈光透镜切除术(KLEx)治疗近视和近视散光的初始屈光和视觉效果。

方法

选取2024年4月至6月所有符合以下纳入和排除标准的眼睛进行研究。该研究纳入年龄大于18岁、视力20/25或更好、等效球镜度(SEQ)为-0.5D至-12.5D的近视患者、剩余基质厚度大于300微米且屈光稳定一年的患者。排除远视、混合散光、角膜厚度小于480微米、角膜疾病、活动性疾病、妊娠、角膜形状异常以及无法承诺进行3个月随访的患者。

结果

共有198只眼(102例患者)纳入统计分析,其中女性45只眼(44.1%),男性57只眼(55.9%),平均年龄23.9±4.8岁。90.4%的眼睛术后裸眼视力达到20/20或更好。预期SEQ与实际SEQ之间的相关性为0.9636,意味着预测性高。我们的研究显示准确性高,100%的眼睛达到预期目标SEQ±1.00D,91.9%的眼睛在预期目标SEQ的0.5D范围内。本研究证实了随访3个月期间屈光稳定性极佳,相对于预期目标仅有微小变化(-0.04D)。

结论

本研究表明,KLEx手术高效且安全,视觉和屈光效果具有良好的可预测性和稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e5/12453037/48f284e04c9d/OPTH-19-3431-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e5/12453037/48f284e04c9d/OPTH-19-3431-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e5/12453037/48f284e04c9d/OPTH-19-3431-g0001.jpg

相似文献

1
Initial Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction Using 2MHz Femtosecond Laser Platform.使用2MHz飞秒激光平台进行角膜屈光透镜切除术的初始视觉和屈光结果
Clin Ophthalmol. 2025 Sep 18;19:3431-3437. doi: 10.2147/OPTH.S548323. eCollection 2025.
2
[Retreatment after keratorefractive lenticule extraction (KLEx) : Results of various methods and influence of the recommendations of the Committee for Refractive Surgery (KRC) on the incidence of retreatment].角膜屈光透镜切除术(KLEx)后的再次治疗:各种方法的结果以及屈光手术委员会(KRC)的建议对再次治疗发生率的影响
Ophthalmologie. 2025 May 5. doi: 10.1007/s00347-025-02239-1.
3
Comparison of Initial Visual Outcomes Following Keratorefractive Lenticule Extraction (KLEx) Using VisuMax 500 Versus VisuMax 800.使用VisuMax 500与VisuMax 800进行角膜屈光透镜切除术(KLEx)后的初始视觉效果比较。
Cureus. 2025 Aug 9;17(8):e89702. doi: 10.7759/cureus.89702. eCollection 2025 Aug.
4
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.准分子激光上皮下角膜磨镶术(LASEK)与准分子激光原位角膜磨镶术(LASIK)治疗近视的比较。
Cochrane Database Syst Rev. 2017 Feb 15;2(2):CD011080. doi: 10.1002/14651858.CD011080.pub2.
5
Comparing The Existing Myopic Keratorefractive Lenticule Extraction (KLEx) Platforms: A Narrative Review.比较现有的近视角膜屈光透镜切除术(KLEx)平台:一项叙述性综述。
Clin Ophthalmol. 2025 Jul 9;19:2189-2202. doi: 10.2147/OPTH.S532742. eCollection 2025.
6
Photorefractive Keratectomy准分子激光原位角膜磨镶术
7
Corneal stability comparison between prophylactic cross-linking with laser refractive surgery technique versus laser refractive surgery technique alone for myopia: a meta-analysis.预防性角膜交联联合激光屈光手术技术与单纯激光屈光手术技术治疗近视的角膜稳定性比较:一项荟萃分析
Graefes Arch Clin Exp Ophthalmol. 2025 Sep 11. doi: 10.1007/s00417-025-06833-6.
8
[Comparison of visual outcomes between corneal topography-guided FS-LASIK and SMILE for myopia and myopic astigmatism: a network meta-analysis].角膜地形图引导的飞秒激光原位角膜磨镶术与小切口基质透镜切除术治疗近视及近视散光的视觉效果比较:一项网状Meta分析
Zhonghua Yan Ke Za Zhi. 2024 Dec 11;60(12):1004-1012. doi: 10.3760/cma.j.cn112142-20240108-00014.
9
A Comparative and Prospective Study of Corneal Consumption and Corneal Biomechanics After SMILE and FS-LASIK Performed on the Contralateral Eyes With High Myopic Astigmatism.高度近视散光患者双眼行 SMILE 与 FS-LASIK 术后角膜消耗与角膜生物力学的对比前瞻性研究
Transl Vis Sci Technol. 2024 Nov 4;13(11):29. doi: 10.1167/tvst.13.11.29.
10
Effects of Ocular Residual Astigmatism on Refractive Outcomes for Myopia Correction After Keratorefractive Lenticule Extraction Surgery.角膜屈光透镜切除术治疗近视后,眼残余散光对屈光矫正效果的影响。
J Refract Surg. 2024 Dec;40(12):e966-e973. doi: 10.3928/1081597X-20241016-02. Epub 2024 Dec 1.

本文引用的文献

1
The outcomes of first-generation (visumax 500) and second-generation (Visumax 800) keratorefractive lenticule extraction surgeries for astigmatism.第一代(Visumax 500)和第二代(Visumax 800)角膜屈光性透镜切除术治疗散光的结果。
Sci Rep. 2024 Sep 27;14(1):22224. doi: 10.1038/s41598-024-73303-0.
2
Comparison of early visual outcomes after SMILE using VISUMAX 800 and VISUMAX 500 for myopia: a retrospective matched case-control study.SMILE 术中应用 VISUMAX 800 和 VISUMAX 500 治疗近视的早期视觉效果比较:一项回顾性配对病例对照研究。
Sci Rep. 2024 May 25;14(1):11989. doi: 10.1038/s41598-024-62354-y.
3
Refractive outcomes of small lenticule extraction (SMILE) Pro® with a 2 MHz femtosecond laser.
2MHz 飞秒激光小透镜提取(SMILE)Pro®的屈光效果。
Int Ophthalmol. 2024 Feb 10;44(1):52. doi: 10.1007/s10792-024-02915-2.
4
Scientific Nomenclature for K (KLEx) Procedures: A Joint Editorial Statement.K(KLEx)程序的科学命名法:联合编辑声明。
J Refract Surg. 2023 Nov;39(11):726-727. doi: 10.3928/1081597X-20231010-0. Epub 2023 Nov 1.
5
Comparison of Intraoperative Time Taken for Docking, Lenticule Dissection, and Overall Workflow for SMILE Performed With the VisuMax 800 Versus the VisuMax 500 Femtosecond Laser.使用VisuMax 800与VisuMax 500飞秒激光进行小切口基质透镜切除术(SMILE)时,对接、透镜分离的术中时间及整体工作流程的比较。
J Refract Surg. 2023 Sep;39(9):648. doi: 10.3928/1081597X-20230726-03. Epub 2023 Sep 1.
6
Refractive and Visual Outcomes of SMILE for Compound Myopic Astigmatism With the VISUMAX 800.SMILE 治疗复合性近视散光的屈光和视觉效果,使用 VISUMAX 800。
J Refract Surg. 2023 May;39(5):294-301. doi: 10.3928/1081597X-20230301-02. Epub 2023 May 1.
7
Large Population Outcomes of Small Incision Lenticule Extraction in Young Myopic Patients.年轻近视患者小切口微透镜取出的大样本量结局。
J Refract Surg. 2022 Aug;38(8):488-496. doi: 10.3928/1081597X-20220623-01. Epub 2022 Aug 1.
8
Biomechanical Effects of tPRK, FS-LASIK, and SMILE on the Cornea.全准分子激光角膜表面切削术、飞秒激光制瓣准分子原位角膜磨镶术和全飞秒激光微小切口基质透镜切除术对角膜的生物力学影响。
Front Bioeng Biotechnol. 2022 Mar 31;10:834270. doi: 10.3389/fbioe.2022.834270. eCollection 2022.
9
Suction stability management in small incision lenticule extraction: incidence and outcomes of suction loss in 4000 consecutive procedures.小切口微透镜提取中的吸力稳定性管理:4000 例连续手术中吸力损失的发生率和结果。
Acta Ophthalmol. 2020 Feb;98(1):e72-e80. doi: 10.1111/aos.14215. Epub 2019 Aug 26.
10
Small incision lenticule extraction (SMILE) techniques: patient selection and perspectives.微小切口基质透镜切除术(SMILE)技术:患者选择与观点
Clin Ophthalmol. 2018 Sep 5;12:1685-1699. doi: 10.2147/OPTH.S157172. eCollection 2018.